MasterSeal M 689 — new waterproofing solutions for the chemical and pharmaceutical industries
High elasticity and crack bridging ensure durability of the membrane even in contact with unstable substrates.
In chemical and pharmaceutical industries, environmentally hazardous chemicals and liquids are frequently an indispensable part of the production process. They require special measures for safe storage and handling. In addition, to prevent pollution of soil and water, secondary containment is required by national laws to control eventual liquid spillages to protect the environment. Especially for this purpose Master Builders Solutions by BASF offers waterproofing solutions also for complex industrial structures.
Secondary containment is theoretically only used when accidental spillage takes place but, in practice, minor quantities of chemicals often escape from valves, connections, joints, etc. These chemicals damage concrete structures and floors and can penetrate into soil causing, in some cases, severe contaminations. When waterproofing capabilities have to be complemented by resistance to chemicals solved in water, special resin based membranes are the best choice as they combine continuous, seamless and crack-bridging waterproofing properties with high chemical resistance.
MasterSeal M 689 combines this high chemical resistance to a wide range of chemicals with an outstanding elasticity and toughness ensuring long term durability of the membrane, even exposed to the most demanding situations. In addition, MasterSeal M 689 has high mechanical resistance, so it can even be used in storage areas with regular traffic. With high elastic and chemical resistance waterproofing membranes such as MasterSeal M 689, secondary containment facilities, basins, pipeline bridges or trafficked impounding basins, are long term protected and any leakage stopped before it reaches soil or groundwater.
MasterSeal M 689 shows high crack bridging capacities, both static (Class A5 according EN 1504 part 2) and dynamic (Class B4.2 according EN 1504 part 2) even at temperatures below zero. In addition, long-term chemical resistance to the exposure to a wide range of different agents even under pressure is proven and documented (Class III according EN 13529). That is why MasterSeal M 689 also fulfils the requirements of the German Wasser-Haushalts-Gesetz (WHG) for the use in so-called LAU (German: Lagern/ Abfüllen/ Umschlagen; English: Storage/ Filling/ Handling) areas in industrial environments.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance